Search Results

The global clinical laboratory services market size was exhibited at USD 213.8 billion in 2022 and it is expected to hold around USD 293.6 billion by 2030, growing at a CAGR of 4.04% from 2022 to 2030.

Tome Biosciences, a gene editing startup that launched in late 2023 with $213 million in funding, will eliminate 131 positions in November, according to a Worker Adjustment and Retraining Act notice.

Backed by ARCH Venture Partners and Fujifilm, as well as technology licensed from MIT, Tome is looking to create curative cell and integrative gene therapies.

Lexaria Bioscience Corp. announces that all data analyses from its simulated pulmonary hypertension clinical study HYPER-H21-3 have been successfully completed with positive safety and efficacy findings.

Lexaria Bioscience Corp. announces that its human clinical study HYPER-H21-3 is expected to complete all dosing and sample collection this week.

Selva Therapeutics, Inc. (“Selva”) today announced new preclinical data demonstrating dosing of SLV213 at picomolar concentrations delivered near complete inhibition of infection by the Omicron variant of SARS-CoV-2 in a human lung epithelial cell line (A549_ACE2).

According to Emergen Research, the global mice model market size was USD 1.30 billion in 2020 and is expected to reach USD 2.13 billion in 2028 and register a revenue CAGR of 6.8% during the forecast period, 2021-2028.

Intercept Pharmaceuticals, Inc. is presenting new data from a planned six-month analysis of its ongoing Phase 2 study 747-213 evaluating a fixed-dose combination of obeticholic acid and bezafibrate in patients with primary biliary cholangitis at Digestive Disease Week® 2024 in Washington, D.C.

Intercept Pharmaceuticals, Inc. today announced new data from a planned six-month analysis of its ongoing Phase 2 study 747-213 evaluating the combination of obeticholic acid (OCA) and bezafibrate in patients with primary biliary cholangitis (PBC) at the European Association for the Study of the Liver (EASL) Congress 2024 being held June 5-8, 2024, in Milan, Italy.